Trial Profile
Long-term safety of drug eluting stents in patients with diabetes mellitus who have single vessel disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- 20 Dec 2015 New trial record